Clinical and basic science aspects of immune pathogenesis of sepsis and peritonitis

Medical Microbiology Letters

Volumn 5, Issue 7, 1996, Pages 386-393

  Holzheimer, R G ^a   Cavaillon, J M ^b   Mosca, F ^c   Haupt, W ^d   Stefani, A ^e   Distefano, R ^f   Torres, A ^g   Cape, P ^h   Aasen, A ⁱ   Andersen, U ^a   Schoeffel, ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UTRECHT UNIVERSITY   (Netherlands)

^g UNIVERSITY OF OSLO   (Norway)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001109125     PISSN: 10184627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor alpha in intravascular and peritonitis models of sepsis. J Infect Dis 1991; 163: 83 - 8
2. Bazzoni F, Beutler B. The Tumor Necrosis Factor ligand and receptor families. New Engl J Med 1996; 334: 1717 -1725
3. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-71
4. Bone RC. The pathogenesis of sepsis. Ann Int Med 1991; 115: 457- 69
5. Bone RC, Balk RA, Fein AM, Perl TM, Wenzel RP, Reines HD, Iberti TJ, Macintyre N, Schein RM. A second large randomized clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med 1995; 23: 994 - 1006
6. Dhainaut IF, Vincent JL, Richard C, Lejeune P, Martin C, Ficrobe L, Stephens S, Ney UM, Sopwith M. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit Care Med 1995; 23: 1461 - 9
7. Dünn DL. Immunomodulation. In: Meakins JL (ed.): Surgical Infections Diagnosis and treatment. Scientific American Medicine Inc. New York 1994: 475 - 92
8. Echtenacher B, Falk W, Marmel DN, Krammer PH. Requirements of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990; 145: 3762 - 66
9. Holzheimer RG, Gro J, Maseizik T, Franke S, Thiede A. Ischemia and endotoxin mediated inflammatory response (TNF, IL-6, IL-10, TNF-RI+II) in aortic aneurysm repair. Shock 1995; Suppl 3: 15 - 6
10. Holzheimer RG, Hirte JF, Reith B, Engelhardt W, Horak KH, Leppert R, Aasen A, Capel P, Urbaschek R, Karch H, Thiede A. Different endotoxin release and IL-6 plasma levels after antibiotic adminstration in surgical intensive care patients. J Endotoxin Res 1996; in press
11. .Holzheimer RG, Molloy R, Mendez VM, O'Riordain D, Curley P, Nestor M, Collins K, Saporoschetz I, Mannick JA, Rodrick ML. Multiple system organ failure may be influenced by macrophage hypoactivation as well as hyperactivation - importance of the double challenge. Eur J Surg 1995; 161 : 795 - 803
12. Holzheimer RG, Molloy RG, O'Riordain DS, Mendez VM, Curley P, Collins K, Nestor M, Saporoschetz I, Mannick JA, Rodrick ML. Long-term immunotherapeutic intervention with pentoxifylline in a mouse model of thermal injury and infection. J Trauma 1995; 38: 757 - 62
13. Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. Arch Surg 1995; 130: 1314 - 20
14. Hurley JC, Louis WJ, Tosolini PA, Carlin JP. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob Agents Chemother 1991; 35: 2388-94
15. Jackson JJ, Kropp H. β-lactam antibiotic induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033 - 41
16. Kirschner M. Die Behandlung der akuten freien Bauchfellentzündung. Langenbecks Arch Klin Chir 1926; 142: 253 - 311
17. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673 - 9
18. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. Dissociation between plasma and monocyte-associated cytokines during sepsis. EUT J Immunoll991;21:2177-84
19. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747-54
20. Matuschak GM. Liver-lung interactions in critical illness. New Horizl994;2:488 - 504
21. Michie HR, Wilmore DW. Sepsis, signals, and surgical sequelae ( a hypothesis). Arch Surg 1990; 125: 531-6
22. Parillo JE. Pathogenesis of human septic shock. Septic shock in humans: advances of understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Int Med 1990; 113: 227 - 42
23. Prins JM, van Agtmael MA, Kuijper EJ, Van Deventer SJH, Speelman P. Antibiotic induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886 - 91
24. Redmond HP, Chavin KD, Bromberg JS, Daly JM. Inhibition of macrophageactivating cytokines is beneficial in the acute septic response. Ann Surg 1991, 214: 502 - 8
25. Rotstein O. Peritonitis and intra-abdominal abscesses. In: Meakins JL (ed): Surgical Infections - Diagnosis and treatment. Scientific American Medicine Inc., New York 1994: 329 - 52
26. Schein M, Wittmann DH, Holzheimer R, Condon RE. Hypothesis: Compartmentalization of cytokines in intraabdominal infection. Surgery 1996 ;119:694-700
27. van de Winkel JGJ, Capel PJA. Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications. Immunol Today 1993; 14:215 21
28. Wittmann DH. Intraabdominal infection - Introduction. World J Surg 1990; 14:145
29. Wittmann DH, Bansal N, Bergstein JM, Wallace JR, Wittmann MM, Aprahamian C. Staged abdominal repair compares favourably with conventional operative therapy for intra-abdominal infections when adjusting for prognostic factors with a logistic model. Theor Surg 1994; 9: 201 - 7